Actions possibles, modalités de l'optimisation médicamenteuse et listes et outils disponibles ,
,
,
11 2. Action de la fiche d'optimisation médicamenteuse ,
, 21 5. Analyse qualitative de l'intérêt
,
,
,
,
Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions, Curr Med Chem, vol.17, issue.6, pp.571-584, 2010. ,
Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging, vol.27, pp.747-758, 2010. ,
Multimorbidity in older adults, Epidemiol Rev, vol.35, pp.75-83, 2013. ,
Polypharmacy trends in office visits by the elderly in the United States, Res Social Adm Pharm, vol.1, issue.3, pp.446-459, 1990. ,
Associations of drug burden index with falls, general practitioner visits, and mortality in older people, Pharmacoepidemiol Drug Saf, vol.23, issue.7, pp.753-758, 2014. ,
Increasing polypharmacy -an individual-based study of the Swedish population, BMC Clin Pharmacol, 2005. ,
Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy, Int J Clin Pharm, 2016. ,
Health outcomes and polypharmacy in elderly individuals: an integrated literature review, J Gerontol Nurs, vol.31, issue.9, pp.4-11, 2005. ,
Accidents iatrogènes médicamenteux chez le sujet âgé hospitalisé en court séjour gériatrique : étude de prévalence et des facteurs de risques, Rev Med Interne, vol.30, issue.5, pp.393-400, 2009. ,
Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital, J Family Med Prim Care, vol.2, issue.2, pp.194-199, 2013. ,
Iatrogénie médicamenteuse chez les patients âgés admis en service d'urgences. Le Pharmacien Hospitalier et Clinicien, vol.47, pp.1-10, 2012. ,
The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden, 2005. ,
Prescription des médicaments chez les personnes âgées : des améliorations sont nécessaires, Presse Med, vol.42, pp.168-170, 2013. ,
Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review, J Am Geriatr Soc, vol.62, issue.12, pp.2261-2272, 2014. ,
Consommation médicamenteuse chez le sujet âgé : Consommation, Prescription, Iatrogénie et Observance, HAS, 2005. ,
Impact de la modification des prescriptions chez les sujets âgés hospitalisés en service de court séjour gériatrique en termes de coût, Rev Med Interne, vol.33, issue.9, pp.482-490, 2012. ,
L'état de santé de la population en France -RAPPORT, 2017. ,
Prescription Médicamenteuse chez le Sujet Agé (PMSA) -Programme Pilote, 2006. ,
Introduction à la rationalisation de la pharmacothérapie chez le sujet âgé, NPG, vol.11, pp.41-45, 2011. ,
The medication appropriateness index at 20: where it started, where it has been, and where it may be going, Drugs Aging, 2013. ,
American Geriatrics Society Updated Beers criteria for potentially inappropriate medication use in older adults: The American Geriatrics Society, 2012. ,
, Beers Criteria Update Expert Panel, J Am Geriatr Soc, vol.60, issue.4, pp.616-631, 2012.
Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française ,
, La Revue de médecine interne, vol.30, pp.592-601, 2009.
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) ,
, Consensus validation, Int J Clin Pharmacol Ther, vol.46, issue.2, pp.72-83, 2008.
STOPP-START : adaptation of a French language screening tool for detecting inappropriate prescriptions in older people, Can J Public Health, vol.100, issue.6, pp.426-431, 2009. ,
, du nouveau dans la détection des prescriptions médicamenteuses inappropriées dans la population âgée, vol.35, pp.341-348, 2010.
Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients, Arch Intern Med, vol.171, issue.11, pp.1013-1019, 2011. ,
START criteria: a new approach to detecting potentially inappropriate prescribing in old age, Eur Geriatr Med, vol.1, pp.45-51, 2010. ,
A comparison of prescribing criteria when applied to older community-based patients, Drugs Aging, 2013. ,
The use of STOPP/START criteria as a screening tool for assessing the appropriatness of medications in the elderly population, Expert Rev Clin Pharmacol, vol.5, pp.187-197, 2012. ,
STOPP/START.v2 criteria : Adaptation into French Language, NPG, vol.15, pp.323-336, 2015. ,
Intervention in elderly patients with multiple morbidities and multiple medications: Results of the prescription and the quality of life, Rev Calid Asist, vol.29, issue.5, pp.256-262, 2014. ,
Views of general practitioners on the use of STOPP&START in primary care: a qualitative study, Acta Clin Belg, 2014. ,
Appropriate prescribing in elderly people: how well can it be measured and optimised?, Lancet, 2007. ,
,
long-term care facility? Results of a randomized, controlled trial, Am J Geriatr Pharmacother, vol.2, pp.257-264, 2004. ,
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly, Am J Med, vol.116, issue.6, pp.394-401, 2004. ,
Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study, Eur J Clin Pharmacol, vol.61, issue.12, pp.921-928, 2005. ,
An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing ,
, Age Ageing, issue.6, pp.612-617, 2004.
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial, J Am Geriatr Soc, 2002. ,
Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study, Drugs Aging, vol.31, issue.4, pp.291-298, 2014. ,
Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria, Clin Pharmacol Ther, vol.89, issue.6, pp.845-854, 2011. ,
Medication reconciliation during transitions of care as a patient safety strategy: a systematic review, Ann Intern Med, vol.158, pp.397-403, 2013. ,
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 2016. ,
, Oct, vol.7, issue.38, pp.2893-2962
Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study, Eur J Clin Pharmacol, vol.61, issue.12, pp.921-928, 2005. ,
Prescription drug use, diagnoses, and healthcare utilization among the elderly, Ann Pharmacother, 2001. ,
The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people, J Am Geriatr Soc, vol.57, issue.1, pp.62-69, 2009. ,
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems, Br J Clin Pharmacol, vol.63, issue.2, pp.187-195, 2007. ,
Polypharmacy Cut-Off for Gait and Cognitive Impairments, Front. Pharmacol, vol.7, p.296, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02135138
Complexity of medication use in the Veterans Affairs healthcare system: Part I: Outpatient use in relation to age and number of prescribers, J Psychiatr Pract, vol.11, issue.1, pp.5-15, 2005. ,
Polypharmacy and prescribing quality in older people, J Am Geriatr Soc, vol.54, issue.10, pp.1516-1523, 2006. ,
Inappropriate Prescribing and Related Hospital Admissions in Frail Older Persons According to the STOPP and START Criteria, Drugs Aging, vol.29, pp.829-837, 2012. ,
START (screening tool to alert doctors to the right treatment) -an evidence-based screening tool to detect prescribing omissions in elderly patients, Age and Ageing, vol.36, pp.632-638, 2007. ,
, Projet OMAGE : un nouveau soin transitionnel pour diminuer les ré-hospitalisations des sujets âgés, 2017.
Prevention of hospital-acquired adverse drug reactions in older people using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment criteria : a cluster randomized controlled trial, Critères STOPP/START. Version, vol.64, p.46, 2015. ,
, Annexe 2 : Fiche d'Optimisation Médicamenteuse